Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 84

1.

New guideline sets the ground rules for routine molecular testing in non-small cell lung cancer.

Pennell NA, Tubbs RR.

J Mol Diagn. 2013 Jul;15(4):413-4. doi: 10.1016/j.jmoldx.2013.05.001. No abstract available.

PMID:
23791446
[PubMed - indexed for MEDLINE]
Free Article
2.

Reflex testing for epidermal growth factor receptor mutation and anaplastic lymphoma kinase fluorescence in situ hybridization in non-small cell lung cancer.

Mino-Kenudson M, Mark EJ.

Arch Pathol Lab Med. 2011 May;135(5):655-64. doi: 10.1043/2011-0029-RAI.1. Review.

PMID:
21526964
[PubMed - indexed for MEDLINE]
3.

[Molecular diagnosis of lung cancer in association with treatment of choice].

Yatabe Y, Shibata N.

Rinsho Byori. 2012 Aug;60(8):786-95. Review. Japanese.

PMID:
23198539
[PubMed - indexed for MEDLINE]
4.

[Significance of molecular technology in diagnosis and therapy of non-small-cell lung cancer].

Chen XX, Zhou CC.

Zhonghua Bing Li Xue Za Zhi. 2012 Aug;41(8):570-2. doi: 10.3760/cma.j.issn.0529-5807.2012.08.017. Chinese. No abstract available.

PMID:
23157756
[PubMed - indexed for MEDLINE]
5.

Epidermal growth factor receptor tyrosine kinase inhibitors as initial therapy for non-small cell lung cancer: focus on epidermal growth factor receptor mutation testing and mutation-positive patients.

Roengvoraphoj M, Tsongalis GJ, Dragnev KH, Rigas JR.

Cancer Treat Rev. 2013 Dec;39(8):839-50. doi: 10.1016/j.ctrv.2013.05.001. Epub 2013 Jun 12. Review.

PMID:
23768755
[PubMed - indexed for MEDLINE]
Free Article
6.

Lung cancer with translocation in the anaplastic lymphoma kinase gene: a disease within a disease.

Ramalingam SS, Khuri FR.

Cancer. 2012 Sep 15;118(18):4370-1. doi: 10.1002/cncr.27402. Epub 2012 Jan 26. No abstract available.

PMID:
22281941
[PubMed - indexed for MEDLINE]
Free Article
7.

[Molecular pathology of lung cancer: key to personalized medicine].

Cheng L, Li Y, Zhang SB, Teng XD.

Zhonghua Bing Li Xue Za Zhi. 2012 Oct;41(10):715-20. doi: 10.3760/cma.j.issn.0529-5807.2012.10.019. Review. Chinese. No abstract available.

PMID:
23302321
[PubMed - indexed for MEDLINE]
8.

Clinical impact of switching to a second EGFR-TKI after a severe AE related to a first EGFR-TKI in EGFR-mutated NSCLC.

Takeda M, Okamoto I, Tsurutani J, Oiso N, Kawada A, Nakagawa K.

Jpn J Clin Oncol. 2012 Jun;42(6):528-33. doi: 10.1093/jjco/hys042. Epub 2012 Mar 28.

PMID:
22457323
[PubMed - indexed for MEDLINE]
Free Article
9.

Lung adenocarcinoma with concurrent exon 19 EGFR mutation and ALK rearrangement responding to erlotinib.

Popat S, Vieira de Araújo A, Min T, Swansbury J, Dainton M, Wotherspoon A, Lim E, Nicholson AG, O'Brien ME.

J Thorac Oncol. 2011 Nov;6(11):1962-3. doi: 10.1097/JTO.0b013e31822eec5e. No abstract available.

PMID:
22005476
[PubMed - indexed for MEDLINE]
10.

Genetic polymorphisms of the epidermal growth factor and related receptor in non-small cell lung cancer--a review of the literature.

Araújo A, Ribeiro R, Azevedo I, Coelho A, Soares M, Sousa B, Pinto D, Lopes C, Medeiros R, Scagliotti GV.

Oncologist. 2007 Feb;12(2):201-10. Review.

PMID:
17296816
[PubMed - indexed for MEDLINE]
Free Article
11.

[Recent changes in the therapeutic strategy for NSCLC in association with new anti-cancer agents].

Yatabe Y.

Rinsho Byori. 2013 Apr;61(4):328-33. Review. Japanese.

PMID:
23855189
[PubMed - indexed for MEDLINE]
12.

Recent advances of novel targeted therapy in non-small cell lung cancer.

Katzel JA, Fanucchi MP, Li Z.

J Hematol Oncol. 2009 Jan 21;2:2. doi: 10.1186/1756-8722-2-2. Review.

PMID:
19159467
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib.

Lynch TJ, Bell DW, Sordella R, Gurubhagavatula S, Okimoto RA, Brannigan BW, Harris PL, Haserlat SM, Supko JG, Haluska FG, Louis DN, Christiani DC, Settleman J, Haber DA.

N Engl J Med. 2004 May 20;350(21):2129-39. Epub 2004 Apr 29.

PMID:
15118073
[PubMed - indexed for MEDLINE]
Free Article
14.

Role of molecular studies in the diagnosis of lung adenocarcinoma.

Yousem SA.

Mod Pathol. 2012 Jan;25 Suppl 1:S11-7. doi: 10.1038/modpathol.2011.156. Review.

PMID:
22214966
[PubMed - indexed for MEDLINE]
Free Article
15.

[Basic principles for the prevention, diagnosis and therapy of lung cancer].

Gyula O, András B, Zoltán B, Katalin B, Attila C, Janos F, Maria G, Akos H, Lászlo K, Lászlo K, Gabor K, Gyorgy L, Judit M, Tamas MF, Zsuzsa M, Pál R, Zsolt O, János S, Zoltán S, István S, Klára S, Jozsef T, Edina T; NEFMI - Nemzeti Erőforrás Minisztérium [Department of Human Resources).

Magy Onkol. 2012 May;56(2):114-32. Hungarian. No abstract available.

PMID:
22724157
[PubMed - indexed for MEDLINE]
Free Article
16.

The impact on the multidisciplinary team of molecular profiling for personalized therapy in non-small cell lung cancer.

Blackhall F, Thatcher N, Booton R, Kerr K.

Lung Cancer. 2013 Feb;79(2):101-3. doi: 10.1016/j.lungcan.2012.10.016. Epub 2012 Nov 22. Review.

PMID:
23182148
[PubMed - indexed for MEDLINE]
17.

[Mutations in the epidermal growth factor receptor: structure and biological function in human tumors].

Pedersen MW, Poulsen HS.

Ugeskr Laeger. 2006 Jun 12;168(24):2354-61. Review. Danish.

PMID:
16822420
[PubMed - indexed for MEDLINE]
18.

Does the addition of vascular endothelial growth factor inhibitors to epidermal growth factor receptor-tyrosine kinase inhibitor overcome T790M acquired resistance?

Hata A, Kaji R, Fujita S, Katakami N.

J Thorac Oncol. 2011 Feb;6(2):404. doi: 10.1097/JTO.0b013e318204a1dc. No abstract available.

PMID:
21252723
[PubMed - indexed for MEDLINE]
19.

Point: should epidermal growth factor receptor mutations be routinely tested for in patients with lung cancer? Yes.

Sterman DH.

Chest. 2013 Mar;143(3):597-600. doi: 10.1378/chest.12-2546. No abstract available.

PMID:
23460149
[PubMed - indexed for MEDLINE]
20.

Importance of molecular features of non-small cell lung cancer for choice of treatment.

Moran C.

Am J Pathol. 2011 May;178(5):1940-8. doi: 10.1016/j.ajpath.2010.12.057. Review.

PMID:
21514411
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk